Steven R Altman insider trades

Open-market stock purchases and sales by Steven R Altman, Director at DexCom Inc, from SEC Form 4 filings since Dec 31, 2009.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +79%.

Recent trades

DateStockTradeValue
May 28, 2026DXCM DexCom IncBought (not open market)—
May 8, 2026DXCM DexCom IncBought (not open market)—

Companies traded

  • DXCM DexCom Inc: 2 buys, 41 sales, last May 28, 2026
  • UBNT Ubiquiti Networks, Inc: 2 buys, last Feb 4, 2014
  • QCOM Qualcomm Inc/de: 92 sales, last Dec 31, 2013
  • AMLN Amylin Pharmaceuticals Inc: other filings, last Apr 5, 2010

Get free alerts when Steven R Altman files a new trade →